Analytical and Clinical Implications of Emerging Cannabinoid Isomers

Author

Ayako Chan-Hosokawa, MS, D-ABFT-FT; Chelsey N. Deisher, MS, D-ABFT-FT; Laura M. Labay, Ph.D., F-ABFT, DABCC-TC.

Impact statement

The 2018 Farm Bill legalized industrial hemp production, making cannabis and cannabis derived products containing less than 0.3% delta-9-tetrahydrocannabinol (Δ9-THC) more accessible. As a result, commercial availability of edibles, dietary supplements, e-cigarettes, and other cannabinoid containing products has increased exponentially. These products could contain cannabinoid isomers (e.g., Δ8-THC), other cannabinoids (e.g., cannabidiol), and even synthetic cannabinoids.

Request a Copy

Request a PDF copy of the poster by completing the information below.

First Name

Last Name

Organization

City/Town

State/Province

What code is in the image? Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.